Skip to main content
Veterinary Medicines

VECOXAN 2.5 MG/ML ORAL SUSPENSION

Authorised
  • Diclazuril

Product identification

Medicine name:
VECOXAN 2.5 MG/ML ORAL SUSPENSION
Vecoxan 2,5 mg/ml Suspension zum Eingeben für Kälber und Lämmer
Active substance:
  • Diclazuril
Target species:
  • Cattle (calf)
  • Sheep (lamb)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Diclazuril
    2.50
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle (calf)
      • Meat and offal
        0
        day
    • Sheep (lamb)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP51BC03
Authorisation status:
  • Valid
Authorised in:
  • Austria
Available in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet Ges.m.b.H.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Productions S.A.
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-00709
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0113/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Portugal
  • Slovakia
  • Spain

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 18/10/2024
Updated on: 21/11/2024

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 18/10/2024
Updated on: 21/11/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 18/10/2024
Updated on: 21/11/2024